City
Epaper

Pulse oximeters overestimate SPo2 levels in non-White patients

By IANS | Published: June 01, 2022 5:54 PM

New York, June 1 Pulse oximeter devices that measure oxygen levels (SPo2) overestimated blood oxygen levels in Covid-19 ...

Open in App

New York, June 1 Pulse oximeter devices that measure oxygen levels (SPo2) overestimated blood oxygen levels in Covid-19 patients who were non-White, finds a new study.

The findings, published in the journal JAMA Internal Medicine, indicate that overestimation of arterial oxygen saturation levels by pulse oximetry occurs in patients of racial and ethnic minority groups with Covid-19 and contributes to unrecognised or delayed recognition of eligibility to receive Covid-19 therapies.

"In this retrospective cohort study of 7,126 patients with Covid-19, an analysis of 1,216 patients with oxygen saturation levels that were concurrently measured by pulse oximetry and arterial blood gas demonstrated that pulse oximetry overestimated arterial oxygen saturation among Asian, Black, and Hispanic patients compared with White patients," according to the journal.

"Separately, among 6,673 patients with pulse oximetry measurements and available covariate data, predicted overestimation of arterial oxygen saturation levels by pulse oximetry among 1,903 patients was associated with a systematic failure to identify Black and Hispanic patients who were qualified to receive Covid-19 therapy and a statistically significant delay in recognising the guideline-recommended threshold for initiation of therapy," it added.

For the study, the team looked at patients with Covid-19 in the Johns Hopkins Health System, between March 2020 and November 2021, to determine whether there is a differential inaccuracy of pulse oximetry by race or ethnicity among patients with Covid-19.

The results of this cohort study suggest that racial and ethnic biases in pulse oximetry accuracy were associated with greater occult hypoxemia, a below-normal level of oxygen in your blood, specifically in the arteries, in Asian, Black, and non-Black Hispanic patients with Covid-19, which was associated with significantly delayed or unrecognised eligibility for Covid-19 therapies among Black and Hispanic patients.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Johns hopkins health systemJama internal medicine
Open in App

Related Stories

TechnologyManaging asymptomatic high blood pressure associated with cardiac, kidney injury: Study

HealthManaging asymptomatic high blood pressure linked to cardiac, kidney injury

HealthChatGPT shows better empathy to patients than doctors: Study

HealthVaccination halves risk of long Covid: Study

TechnologyDeveloping postoperative delirium is linked to a quicker rate of cognitive decline

Health Realted Stories

HealthNitin Gadkari undergoes tests in Mumbai hospital, gets clean bill of health

HealthAfter seven years, WHO updates antibiotic-resistant bacteria list

HealthExplained: What is Hepatitis A that is causing an outbreak in Kerala

HealthZomato CEO wants Indians to eat ‘roti’ instead of ‘naan’ to stay healthy

LifestyleBenefits Of Applying Ice Cubes on Face